We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$28.1B
AUM Growth
+$221M
Cap. Flow
-$28.9B
Cap. Flow %
-102.77%
Top 10 Hldgs %
13.04%
Holding
2,341
New
Increased
Reduced
Closed
1,870

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$644M
2
MSFT icon
Microsoft
MSFT
+$558M
3
TSM icon
TSMC
TSM
+$429M
4
PEP icon
PepsiCo
PEP
+$350M
5
CSX icon
CSX Corp
CSX
+$343M

Sector Composition

Rank Sector Weight
1 Technology 23.16%
2 Consumer Discretionary 13.96%
3 Healthcare 13.95%
4 Industrials 10.47%
5 Financials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVRA icon
1826
Zevra Therapeutics
ZVRA
$563M
-33,046
Closed -$175K
SCPH
1827
DELISTED
scPharmaceuticals
SCPH
-20,430
Closed -$150K
CLDT
1828
Chatham Lodging
CLDT
$630M
0
CMPX icon
1829
Compass Therapeutics
CMPX
$373M
-25,305
Closed -$99.3K
HPP
1830
Hudson Pacific Properties
HPP
$834M
-2,601
Closed -$167K
STXS icon
1831
Stereotaxis
STXS
$129M
-10,851
Closed -$24.4K
AMBP icon
1832
Ardagh Metal Packaging
AMBP
$2.86B
-18,616
Closed -$91.4K
LUNA
1833
DELISTED
Luna Innovations Incorporated
LUNA
-13,419
Closed -$118K
NPKI
1834
NPK International
NPKI
$1.21B
0
IMRX icon
1835
Immuneering
IMRX
$279M
-18,368
Closed -$104K
SVRA icon
1836
Savara
SVRA
$1.13B
-37,562
Closed -$84.6K
TNYA icon
1837
Tenaya Therapeutics
TNYA
$168M
0
RAIN
1838
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-16,259
Closed -$150K
HOWL icon
1839
Werewolf Therapeutics
HOWL
$20.8M
0
TUSK icon
1840
Mammoth Energy Services
TUSK
$132M
-15,365
Closed -$91.5K
ATNM icon
1841
Actinium Pharmaceuticals
ATNM
$27M
-12,901
Closed -$136K
RBOT.WS
1842
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
-290,458
Closed -$85.2K
VIGL
1843
DELISTED
Vigil Neuroscience
VIGL
0
EEX
1844
DELISTED
Emerald Holding
EEX
-24,586
Closed -$91.9K
ESPR
1845
DELISTED
Esperion Therapeutics
ESPR
-18,100
Closed -$93.4K
BIVI icon
1846
BioVie
BIVI
$10.3M
-183
Closed -$121K
VRCA icon
1847
Verrica Pharmaceuticals
VRCA
$86.2M
0
TRUE
1848
DELISTED
TrueCar
TRUE
-28,884
Closed -$77K
ZYME icon
1849
Zymeworks
ZYME
$1.68B
-18,289
Closed -$159K
PDSB icon
1850
PDS Biotechnology
PDSB
$38.1M
-10,988
Closed -$89.9K

Similar funds

Man Group's Q1 2023 Portfolio in Review

As of Q1 2023, Man Group held 2,341 positions worth $28.1B, up 0.79% from $27.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group withdrew a net $28.9B in Q1 2023, closing 1,870 positions. Its most notable exit was Apple, an estimated $644M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Man Group fully exited Apple in Q1 2023, selling an estimated $644M.
  • Man Group's ten largest holdings make up 13% of its $28.1B portfolio in Q1 2023.
  • Man Group opened 0 new positions and closed 1,870 in Q1 2023.
  • Man Group's portfolio value rose 0.79% quarter-over-quarter to $28.1B.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.